ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe

Rich, Anna; Baldwin, David R; Beckett, Paul; Berghmans, Thierry; Boyd, Jeanette; Faivre-Finn, Corinne; Galateau-Salle, Françoise; Gamarra, Fernando; Grigoriu, Bogdan; Hansen, Niels Chr.; Hardavella, Georgia; Jakobsen, Erik; Jovanović, Dragana; Konsoulova, Assia; Massard, Gilbert; McPhelim, J.; Meert, Anne-Pascale; Milroy, Robert; Mutti, Luciano; Paesmans, Marianne; Peake, Michael; Putora, Paul Martin; Ruysscher, Dirk De; Sculier, Jean-Paul; Schepereel, A; Subotic, Dragan; Schil, Paul Van; Blum, Torsten

doi:10.1183/13993003.00610-2018

Cited by 10 publications

(8 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to a European Respiratory Society (ERS) statement on harmonized standards for lung cancer registration and lung cancer services in Europe, standards differ across the European countries, making for different diagnostic pathway for lung cancer. 28 A harmonized standard is in progress, and in Denmark a fast track programme is implemented. The results of the present study must be understood in this context.…”

Section: Limitations Of the Studymentioning

confidence: 99%

Patient perspectives and experience on the diagnostic pathway of lung cancer: A qualitative study

Christensen

Huniche

2020

SAGE Open Medicine

View full text Add to dashboard Cite

Objectives: Lung cancer is one of the most common types of cancer, with high mortality rate and a significant burden of symptoms. It is therefore important to assess patients’ perceived quality of life during the diagnostic process and treatment. Knowledge of and attention to patients’ perspectives, experiences, and expectations in relation to lung cancer diagnostic pathways is limited. The aim of the study is to contribute with patients’ and relatives’ experiences with and their assessment of the quality of a hospital-based lung cancer diagnostic pathway. Methods: A qualitative study was conducted, comprising participant observation with 20 patients and semi-structured interviews with further 19 patients referred to the Lung Cancer Package, which initiates a fast track diagnostic pathway in a hospital setting. Data were obtained over a period of 9 months and analysed in collaboration with an interdisciplinary team of health professionals. The purpose was to further develop existing management strategies of the fast track diagnostic pathway based on patient’s perspectives. Results: Patients associated the fast track diagnostic pathway with high levels of anxiety due to the immediate risk of a lung cancer diagnosis. Although patients experienced the fast track programme as very challenging, they still wanted to move through the diagnostic pathway as quickly as possible. The patients expressed a need for support from relatives and repeatedly required information in multiple formats from health professionals throughout the diagnostic pathway. Conclusions: The study provided insight into the need for developing the fast track diagnostic pathway with a focus on patient anxiety, network involvement, and information strategies. The results qualified clinical practice with an increased focus on managing patients’ anxiety, raised awareness to involve relatives in the diagnostic process, and relaying information in dialogue with patients and their relatives, including management strategies to support patients through diagnostic investigations in the fast track programme.

show abstract

Section: Limitations Of the Studymentioning

confidence: 99%

Patient perspectives and experience on the diagnostic pathway of lung cancer: A qualitative study

Christensen

Huniche

2020

SAGE Open Medicine

View full text Add to dashboard Cite

show abstract

“…With conflicting recommendations from available guidelines, it is reasonable to assume this will lead to variation in lung cancer surgical care. Recent studies have reported important quality gaps in treatment delivery (17) and unwarranted care variation (18), leading to significant variation in preoperative cardiopulmonary assessment practices (19) and surgical resection rates (20). Whether there are also differences in preoperative diagnostic testing, leading to variation in proportion of patients being operated without a preoperative pathological diagnosis, remains to be clarified.…”

Section: Introductionmentioning

confidence: 99%

Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice?

Ghamati¹,

Li²,

Heijden³

et al. 2021

J Thorac Dis

View full text Add to dashboard Cite

Background: There are discordances in the guidelines regarding the need to acquire histological diagnosis before surgical treatment of (presumed) lung cancer. Preoperative histological confirmation is always encouraged in this setting to prevent unnecessary surgery or when sublobar resection for small-sized tumors is considered. The aim of this retrospective cohort study was to assess the proportion of patients undergoing lung cancer resection in the Netherlands without preoperative pathological confirmation, based on the intraoperative pathological diagnosis (IOD) rate, and to determine characteristics that may influence IOD frequency. Methods: Data on 10,226 patients, who underwent surgical treatment for lung cancer from 2010 to 2015, were retrieved from the Netherlands National Cancer Registry. We registered an IOD when the date of diagnosis equaled the date of the first surgical intervention. Tabulations and multivariable logistic regression were used to identify predictive parameters for IOD. Results: 36% of surgical procedures were classified as IOD, and decreased with increasing tumor size and extent of surgery (57% for segmentectomy, 39% for lobectomy and 11% for pneumonectomy). IOD was more frequently observed in adenocarcinoma (41%), varied between hospitals from 13% to 66% and was less common when patients were referred from a hospital where thoracic surgery was not performed. Previous history of cancer did not affect IOD. Conclusions: More than one-third of patients with suspected lung cancer in the Netherlands was operated without preoperative histological confirmation. There was significant variation in IOD rates between different hospitals, which deserves further detailed analysis when striving for uniform surgical quality of care for patients with lung cancer.

show abstract

“…A paradigm change occurred over these past years, which resulted in the recommendation that metastatic lung cancer patients acquire early palliative treatment. 12 There should be no distinction between palliative care and disease-modifying treatments. Rather, it should be incorporated into treating lung cancer from the onset.…”

Section: Palliative Care: Definitionmentioning

confidence: 99%

“…20 Physical complaints could be improved by surgery, radiotherapy, or systemic therapy. 12 Palliative surgery could afford very effective pain relief in various scenarios. Surgical debulking of large, slow-growing tumors can alleviate discomfort and is appropriate in patients where the procedure's estimated morbidity is low.…”

Section: Palliative Care Treatment Options For Patients With Lung Cancermentioning

confidence: 99%

Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?

Haryati

Rahmawaty

Wanahari

2023

View full text Add to dashboard Cite

Lung cancer is among the most prevalent cancers and the primary cause of cancer-related mortality. Despite advances in treatment, patients often have a poor prognosis, with a limited survival period, particularly in advanced stages. Significant morbidity is linked with lung cancer, and symptoms are frequently inadequately controlled, resulting in a considerable symptom burden for patients and their family caregivers. It is typically accompanied by an overall reduction in one’s quality of life (QoL). Palliative care is an established therapy paradigm that successfully enhances symptom management and physical and mental health. It can be initiated as soon as the patient develops symptoms (even in the early stage) or is diagnosed with a late stage. Over the past few decades, palliative care has become a vital part of comprehensive care for people, especially those with advanced diseases. Early palliative care (EPC) integration within the oncology setting is more effective than standard care in enhancing the patient’s QoL and length of survival, resulting in less intrusive end-of-life care. When caring for lung cancer patients, medical practitioners must remember their duty to cure occasionally, routinely alleviate, and constantly comfort the patient. Treating physical symptoms, illness comprehension, coping, and psychological and spiritual anguish are all vital components. Intervention strategies by multidisciplinary teams concentrating on the patient and their family and dealing with the circumstances are essential. All health providers should prioritize palliative and end-of-life care to enhance care and assist patients and their families in navigating the final period of life.

show abstract

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe

Cited by 10 publications

References 69 publications

Patient perspectives and experience on the diagnostic pathway of lung cancer: A qualitative study

Patient perspectives and experience on the diagnostic pathway of lung cancer: A qualitative study

Surgery without preoperative histological confirmation of lung cancer: what is the current clinical practice?

Implementing Palliative and End-of-Life Care in Lung Cancer: When to Start?

Contact Info

Product

Resources

About